-
1دورية أكاديمية
المؤلفون: Sferrazza G; a Institute of Translational Pharmacology , National Research Council , Rome , Italy., Siviero PD; b Principia SGR s.p.a ., Milan , Italy., Nicotera G; a Institute of Translational Pharmacology , National Research Council , Rome , Italy., Turella P; c Pharma Unit - pre-submission Analysis and Strategy , Intexo S.r.l. , Rome , Italy., Serafino A; a Institute of Translational Pharmacology , National Research Council , Rome , Italy., Blandizzi C; d Department of clinical and Experimental Medicine, Unit of Pharmacology and Pharmacovigilance , University of Pisa , Pisa , Italy., Pierimarchi P; a Institute of Translational Pharmacology , National Research Council , Rome , Italy.
المصدر: Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2017 Sep; Vol. 10 (9), pp. 1007-1019. Date of Electronic Publication: 2017 Jul 06.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278296 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-2441 (Electronic) Linking ISSN: 17512433 NLM ISO Abbreviation: Expert Rev Clin Pharmacol Subsets: MEDLINE
-
2دورية أكاديمية
المؤلفون: Kleijnen S; National Health Care Institute (Zorginstituut Nederland), PO Box 320, 110 XH Diemen, The Netherlands; University of Utrecht, PO Box 80082, 3508 TB Utrecht, The Netherlands. Electronic address: skleijnen@zinl.nl., Toenders W; ToendersdeGroot Consultants, Boomstede 281, 3608 AN Maarssen, The Netherlands., de Groot F; ToendersdeGroot Consultants, Boomstede 281, 3608 AN Maarssen, The Netherlands., Huic M; Agency for Quality and Accreditation in Health Care and Social Welfare (Agencija za kvalitetu i akreditaciju u zdravstvu i socijalnoj skrbi), Planinska 13, HR-10000 Zagreb, Croatia., George E; National Institute for Health and Care Excellence, 10 Spring Gardens, London SW1A 2BU, England, United Kingdom., Wieseler B; The Institute for Quality and Efficiency in Healthcare (Institut für Qualität und Wirtschaftlichkeit im Gesundheidswesen), Im Mediapark 8, D-50670 Köln, Germany., Pavlovic M; French National Authority for Health (Haute Autorité de Santé), 2, avenue du Stade de France, 93218 Saint-Denis La Plaine Cedex, France., Bucsics A; Association of Austrian Social Insurance Institutions (Hauptverband der Österreichischen Sozialversicherungsträger), Postfach 600, 1031 Vienna, Austria; University of Vienna, Brünner Straße 72, 1210 Vienna, Austria., Siviero PD; Italian Medicines Agency (Agenzia Italiana del Farmaco), Via del Tritone, 181, 00187 Rome, Italy., van der Graaff M; National Health Care Institute (Zorginstituut Nederland), PO Box 320, 110 XH Diemen, The Netherlands., Rdzany R; Agency for Health Technology Assessment and Tariff System in Poland (Agencja Oceny Technologii Medycznych i Taryfikacji), ul. I. Krasickiego 26, 02-611 Warsaw, Poland., Kristensen FB; Danish Health and Medicines Authority (Sundhedsstyrelsen), Axel Heides Gade 1, 2300 Copenhagen S, Denmark; University of Southern Denmark, Campusvej 55, DK 5230 Odense M, Denmark., Goettsch W; National Health Care Institute (Zorginstituut Nederland), PO Box 320, 110 XH Diemen, The Netherlands; University of Utrecht, PO Box 80082, 3508 TB Utrecht, The Netherlands.
المصدر: Health policy (Amsterdam, Netherlands) [Health Policy] 2015 May; Vol. 119 (5), pp. 569-76. Date of Electronic Publication: 2015 Feb 07.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review
بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8409431 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-6054 (Electronic) Linking ISSN: 01688510 NLM ISO Abbreviation: Health Policy
-
3دورية أكاديمية
المؤلفون: Eichler HG; European Medicines Agency (EMA), London, UK., Baird LG, Barker R, Bloechl-Daum B, Børlum-Kristensen F, Brown J, Chua R, Del Signore S, Dugan U, Ferguson J, Garner S, Goettsch W, Haigh J, Honig P, Hoos A, Huckle P, Kondo T, Le Cam Y, Leufkens H, Lim R, Longson C, Lumpkin M, Maraganore J, O'Rourke B, Oye K, Pezalla E, Pignatti F, Raine J, Rasi G, Salmonson T, Samaha D, Schneeweiss S, Siviero PD, Skinner M, Teagarden JR, Tominaga T, Trusheim MR, Tunis S, Unger TF, Vamvakas S, Hirsch G
المصدر: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2015 Mar; Vol. 97 (3), pp. 234-46. Date of Electronic Publication: 2015 Feb 04.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
مواضيع طبية MeSH: Licensure*, Drug Approval/*legislation & jurisprudence , Drug Approval/*methods , Drug Discovery/*legislation & jurisprudence, Humans
-
4دورية أكاديمية
المؤلفون: Montilla S; Italian Medicines Agency (AIFA), Rome, Italy. Electronic address: s.montilla@aifa.gov.it., Marchesini G; Unit of Metabolic Diseases, S. Orsola-Malpighi University Hospital, Bologna, Italy., Sammarco A; Italian Medicines Agency (AIFA), Rome, Italy., Trotta MP; Italian Medicines Agency (AIFA), Rome, Italy., Siviero PD; Italian Medicines Agency (AIFA), Rome, Italy., Tomino C; Italian Medicines Agency (AIFA), Rome, Italy., Melchiorri D; Dept. Physiology and Pharmacology, University of Rome 'La Sapienza', Rome, Italy., Pani L; Italian Medicines Agency (AIFA), Rome, Italy.
مؤلفون مشاركون: AIFA Anti-diabetics Monitoring Group
المصدر: Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2014 Dec; Vol. 24 (12), pp. 1346-53. Date of Electronic Publication: 2014 Oct 06.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9111474 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1590-3729 (Electronic) Linking ISSN: 09394753 NLM ISO Abbreviation: Nutr Metab Cardiovasc Dis Subsets: MEDLINE
مواضيع طبية MeSH: Adamantane/*analogs & derivatives , Diabetes Mellitus, Type 2/*drug therapy , Hypoglycemic Agents/*therapeutic use , Nitriles/*therapeutic use , Peptides/*therapeutic use , Pyrazines/*therapeutic use , Pyrrolidines/*therapeutic use , Triazoles/*therapeutic use , Venoms/*therapeutic use, Adamantane/administration & dosage ; Adamantane/adverse effects ; Adamantane/therapeutic use ; Aged ; Blood Glucose/metabolism ; Body Weight ; Diabetes Mellitus, Type 2/epidemiology ; Drug Utilization ; Drug-Related Side Effects and Adverse Reactions ; Exenatide ; Female ; Glycated Hemoglobin/analysis ; Humans ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/adverse effects ; Italy/epidemiology ; Male ; Metformin/therapeutic use ; Middle Aged ; Monitoring, Physiologic ; Nitriles/administration & dosage ; Nitriles/adverse effects ; Peptides/administration & dosage ; Peptides/adverse effects ; Pyrazines/administration & dosage ; Pyrazines/adverse effects ; Pyrrolidines/administration & dosage ; Pyrrolidines/adverse effects ; Registries ; Sex Factors ; Sitagliptin Phosphate ; Triazoles/administration & dosage ; Triazoles/adverse effects ; Venoms/administration & dosage ; Venoms/adverse effects ; Vildagliptin
-
5دورية أكاديمية
المؤلفون: Russo P; OSMED Office, Italian Medicines Agency. Electronic address: p.russo@aifa.gov.it., Mennini FS; CEIS Sanità (Centre for Health Economics and Management), Faculty of Economics, University 'Tor Vergata' Rome; Faculty of Statistics, University 'La Sapienza' Rome., Siviero PD; Center for Strategic Studies, Italian Medicines Agency., Rasi G; Italian Medicines Agency, General Director, Italy.
المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2010 Oct; Vol. 21 (10), pp. 2081-2087. Date of Electronic Publication: 2010 Mar 24.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Drug Utilization* , Health Personnel* , Health Services Accessibility*, Antineoplastic Agents/*economics , Antineoplastic Agents/*supply & distribution , Marketing/*economics, Europe ; Humans